𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neutrophil differentiation from human-induced pluripotent stem cells

✍ Scribed by Tatsuya Morishima; Ken-ichiro Watanabe; Akira Niwa; Hisanori Fujino; Hiroshi Matsubara; Souichi Adachi; Hirofumi Suemori; Tatsutoshi Nakahata; Toshio Heike


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
326 KB
Volume
226
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Induced pluripotent stem (iPS) cells are of potential value not only for regenerative medicine, but also for disease investigation. The present study describes the development of a neutrophil differentiation system from human iPS cells (hiPSCs) and the analysis of neutrophil function and differentiation. The culture system used consisted of the transfer of hiPSCs onto OP9 cells and their culture with vascular endothelial growth factor (VEGF). After 10 days, TRA 1‐85^+^CD34^+^VEGF receptor‐2 (VEGFR‐2)^high^ cells were sorted and co‐cultured with OP9 cells in the presence of hematopoietic cytokines for 30 days. Floating cells were collected and subjected to morphological and functional analysis. These hiPSC‐derived neutrophils were similar to peripheral blood mature neutrophils in morphology, contained functional neutrophil specific granules, and were equipped with the basic functions such as phagocytosis, superoxide production, and chemotaxis. In the process of differentiation, myeloid cells appeared sequentially from immature myeloblasts to mature segmented neutrophils. Expression patterns of surface antigen, transcription factors, and granule proteins during differentiation were also similar to those of granulopoiesis in normal bone marrow. In conclusion, differentiation of mature neutrophils from hiPSCs was successfully induced in a similar process to normal granulopoiesis using an OP9 co‐culture system. This system may be applied to elucidate the pathogenesis of various hematological diseases that affect neutrophils. J. Cell. Physiol. 226: 1283–1291, 2011. Β© 2010 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Generation of human induced pluripotent
✍ Moriguchi Hisashi; Chung Raymond T.; Mihara Makoto; Sato Chifumi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 277 KB

The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi

Induced pluripotent stem cells generated
✍ Reto Eggenschwiler; Tobias Cantz πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. Here, we generate mouse induced pluripotent

Teratomas from pluripotent stem cells: A
✍ Chui-Yee Fong; Kalamegam Gauthaman; Ariff Bongso πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 1 views

## Abstract Although basic research on human embryonic stem cells (hESCs) at the laboratory bench has progressed with enviable speed there has been little head way in terms of its clinical application. A look at the Internet however shows several stem cell clinics worldwide offering direct transpla

Reprogramming the pluripotent cell cycle
✍ Prachi N. Ghule; Ricardo Medina; Christopher J. Lengner; Matthew Mandeville; Men πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 461 KB πŸ‘ 2 views

## Abstract Induced pluripotent stem (iPS) cells derived from terminally differentiated human fibroblasts are reprogrammed to possess stem cell like properties. However, the extent to which iPS cells exhibit unique properties of the human embryonic stem (hES) cell cycle remains to be established. h